US Broker Ratings

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Powerhouse with 6.66% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) has positioned itself as a leading player in the healthcare sector, particularly within the medical care facilities industry. With a robust market capitalization of..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Navigating a Potential 20.76% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a pioneering biopharmaceutical company, is making waves in the biotechnology sector with its cutting-edge approach to medicinal therapies. Founded in 2003 and headquartered in Miami,..

Genmab A/S (GMAB) Stock Analysis: Exploring a 42% Potential Upside for Investors

For investors with a keen eye on the biotechnology sector, Genmab A/S (GMAB) represents a compelling opportunity. This Danish company, with a market capitalization of $13.9 billion, is positioned uniquely..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Gem with 86% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a key player in the biotechnology sector, is making waves with its promising portfolio of treatments tackling severe endocrinologic, oncologic, metabolic, and neurologic disorders. Headquartered..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Buy Ratings and Promising Upside Potential of 19.58%

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology industry with its notable presence in the oncology sector, focusing on the development and commercialization of innovative cancer treatments. Headquartered in..

Moderna, Inc. (MRNA) Investor Outlook: Analyzing the 71.73% Potential Upside Amidst Challenges

Moderna, Inc. (NASDAQ: MRNA), a pioneering biotechnology company, has been a subject of intense investor scrutiny as it navigates the complexities of the post-pandemic landscape. Known for its groundbreaking work..

Tenet Healthcare Corporation (THC) Stock Analysis: Unpacking a 19% Potential Upside with Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC), a leading entity in the healthcare sector, is capturing investor attention with its robust market position and promising growth potential. With a market capitalization of..

Walgreens Boots Alliance (WBA) Stock Analysis: Navigating Challenges with an 8.38% Dividend Yield

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the healthcare and pharmaceutical retail sector, has been a focal point for investors seeking stability and dividends in a volatile market...

Elevance Health, Inc. (ELV) Stock Analysis: Exploring the 26.65% Upside Potential

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, stands as a formidable player in the U.S. healthcare sector. With a robust market capitalization of $66.2 billion,..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and 14% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands as a prominent player in the healthcare sector, particularly within the medical distribution industry. With a substantial market capitalization of $37.57 billion, this Ohio-headquartered..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Strong Buy Ratings and 18.45% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV) stands out in the healthcare sector as a formidable player in the Diagnostics & Research industry. With a significant market capitalization of $30.58 billion, IQVIA..

Edwards Lifesciences Corporation (EW) Stock Analysis: A Look at Growth and Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the healthcare sector, continues to capture the attention of investors with its innovative medical devices designed for cardiovascular treatments. With a..

Mettler-Toledo International, Inc. (MTD): Investor Outlook and Valuation Insights Amidst Modest Growth

Mettler-Toledo International, Inc. (MTD), a prominent player in the healthcare sector, specifically in the diagnostics and research industry, is capturing investor attention with its robust market presence and diverse product..

Humana Inc. (HUM) Stock Analysis: Evaluating a 9.12% Potential Upside Amidst Healthcare Growth

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, has captured the attention of investors with its robust market position and promising growth prospects. As a leading provider..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Key Insights into the 33% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading player in the biotechnology industry, commands significant attention with its robust portfolio of therapies targeting cystic fibrosis (CF) and a promising pipeline addressing..

Quest Diagnostics (DGX) Stock Analysis: Steady Growth and a 6.34% Upside Potential

For individual investors seeking exposure to the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents a compelling opportunity. With a market capitalization of $19.79 billion, Quest Diagnostics is a significant..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Innovator with a Steady Growth Trajectory

Doximity, Inc. (DOCS) stands out as a key player in the healthcare sector, operating as a digital platform tailored for medical professionals. With a robust market capitalization of $12.47 billion,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Analyst Ratings Signal a 22% Upside Potential

GE HealthCare Technologies Inc. (NYSE: GEHC) has garnered significant attention in the healthcare sector, boasting a robust market capitalization of $32.87 billion and a diverse portfolio spanning imaging, patient care..

Haleon plc (HLN) Stock Analysis: Exploring a 21.66% Upside Potential in the Healthcare Sector

Haleon plc (HLN), a prominent player in the global healthcare industry, presents a compelling opportunity for investors seeking exposure to the drug manufacturing sector, specifically within the realm of specialty..

Zimmer Biomet Holdings, Inc. (ZBH): Investor Outlook with an 11.74% Upside Potential

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) continues to draw significant attention from investors keen on the healthcare sector, particularly those focused on medical devices. With a market capitalization of $19.66..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds